Oct 16 (Reuters) - Swiss drugmaker Novartis has terminated a mid-stage study testing its drug Fabhalta in patients with a ...

Dr. Rasha Alawieh, an assistant professor at Brown Medicine, was prevented from returning to the United States from Lebanon ...

Liquid chromatography–tandem mass spectrometry (LC–MS/MS) and microbiome data reveal kidney markers of diabetic disease. Diabetic kidney disease (DKD), a type of kidney damage caused by diabetes, is ...

Two women have developed kidney-related complications following Cesarean deliveries at the New Medical College Hospital in ...

Pat McAfee often divides the crowd with his energy. While many love his work on ESPN and College GameDay, there are quite a ...

Estuary Biotherapeutics, Inc., a biotechnology company developing genetic medicines for patients with serious kidney diseases, today announced its launch with $103 million in total committed financing ...

Estuary Biotherapeutics has swum out of stealth with $103 million in funding to power a pair of gene therapies into clinical ...

The Series A round, which was led by RA Capital, will help fund the development of two genetic medicines designed to treat an ...

Burlington High School athlete just learned that she's one step closer to getting a kidney transplant. Her soccer coach and ...

A northwest Ohio family is turning their family’s experience with kidney disease into advocacy as the Kidney Foundation of ...

Yet another reason to load your dinner plate with healthy vegetables.